Talk:Nimotuzumab

reads like an advert
reads like an advert - especially the Develeopment section. Rod57 (talk) 21:34, 10 December 2009 (UTC)

At least it used to be one. Now it slowly turns into an article.141.80.79.32 (talk) 13:56, 15 December 2009 (UTC)

YM Biosciences role
In the Development section : Can YM biosciences role be clarified ? Is it the current owner of all rights to nimotuzumab ? Rod57 (talk) 05:12, 11 December 2009 (UTC)

Adverse effects?
How come nearly all othe mAbs have significant adverse effects and this one doesn't? 46.138.95.18 (talk) 07:46, 6 November 2011 (UTC)

Clinical Tests
How can one voluntarily participate in the clinical test?

CAS number
Merck Index Monograph number 10585 reports the CAS Registry Number is 780758-10-3. CHEMnet reports the CAS Registry Number is 828933-51-3. It is listed in MESH, here http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?term=780758-10-3&rn=1&rr=1&rn=&rr=&term=Nimotuzumab. This NIH source lists both CAS numbers. a search of chemspider under either registry number as well as Nimotuzumab turned up nothing. Pubchem substance yielded two hits (each listing both CAS numbers) SID 135356483 and SID 160698394. Jytdog (talk) 01:01, 11 May 2014 (UTC)